Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-19-060091

Options or other derivatives

  • Chief Technology Officer acquired 626,201.72 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thornton Michael Milos · Chief Technology Officer

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-11 Grant or award : show line 1 in the form Stock option (right to buy) +575,906 575,906 D
2019-12-11 Grant or award : show line 2 in the form Series A Convertible Preferred Stock +43.72 $1,143.68 $50,001 43.72 D
2019-12-11 Grant or award : show line 3 in the form Warrants +50,252 50,252 D
Loading xslF345X03/doc4.xml…